Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)-Reference-Cited by-同舟云学术

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

Published:2011-07 Issue:10 Volume:47 Page:1476-1483
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Patel Poulam M.,Suciu Stefan,Mortier Laurent,Kruit Wim H.,Robert Caroline,Schadendorf Dirk,Trefzer Uwe,Punt Cornelis J.A.,Dummer Reinhard,Davidson Neville,Becker Juergen,Conry Robert,Thompson John A.,Hwu Wen-Jen,Engelen Kristel,Agarwala Sanjiv S.,Keilholz Ulrich,Eggermont Alexander M.M.,Spatz Alain

Funder

UK National Cancer Research Network

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia;de Vries;Int J Cancer,2003

2. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

3. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma;Balch;J Clin Oncol,2001

4. An evidence-based staging system for cutaneous melanoma;Balch;CA Cancer J Clin,2004

5. Prognostic factors in 1, 521 melanoma patients with distant metastases;Barth;J Am Coll Surg,1995

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic melanoma (FLAT);Frontiers in Oncology;2024-09-04

2. Biological and metabolomics-guided isolation of tetrahydrofurofuran lignan from Croton spp. with antiproliferative activity against human melanoma cell line;Fitoterapia;2024-09

3. Review of recent advances in managing periocular skin malignancies;Frontiers in Oncology;2024-03-04

4. Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?;The Cancer Journal;2024-03

5. Real‐World Outcomes of Inoperable and Metastatic Cutaneous Head and Neck Melanoma Patients;The Laryngoscope;2024-01-17